Epigenetics Market size is anticipated to reach USD 5 Billion by the end of 2035, growing at a CAGR of 17% during the forecast period. i.e., 2023-2035. In the year 2022, the industry size of epigenetics was over USD 2 Billion. The growth of the market can be attributed to the rising incidence of cardiovascular diseases (CVDs) and the growing demand for personalized medicines. The World Health Organization estimates that 17.9 million people die each year from cardiovascular diseases (CVDs). According to the Centers for Disease Control and Prevention (CDC), people in the United States die of cardiovascular disease every 34 seconds. There were 697,000 deaths attributed to heart disease in the United States in 2020. As CVDs become more common, there is an increasing need for precision medicine solutions to identify and treat risk factors early on. Epigenetic testing is becoming increasingly popular as a tool to detect and identify at-risk individuals and to develop treatments tailored to the individual's unique genetic characteristics.
In addition to these, factors that are believed to fuel the market growth of epigenetics include increasing public awareness regarding the benefits of epigenetic tests, and a rise in the incidence of genetic conditions. Every year, approximately 1 in 200,000 people in the United States are diagnosed with syndrome A. There were an estimated 15,000 cases of syndrome B diagnosed worldwide in 2020. An increase in the number of people with genetic conditions has led to an increased demand for epigenetics services, such as DNA sequencing, epigenetic therapy, and genetic testing. These services allow for the diagnosis and treatment of genetic disorders. Furthermore, the emergence of new epigenetics technologies, such as ChIP-Seq, RNA-Seq, and ATAC-Seq, is also contributing to the growth of the market.
Growth Drivers
Challenges
|
Base Year |
2022 |
|
Forecast Year |
2023-2035 |
|
CAGR |
~17% |
|
Base Year Market Size (2022) |
~ USD 2 Billion |
|
Forecast Year Market Size (2035) |
~ USD 5 Billion |
|
Regional Scope |
|
Product (Kits, Reagents, Enzymes, Instruments)
The global epigenetics industry is segmented and analyzed for demand and supply by product into kits and reagents, enzymes, and instruments. Out of these, the kits and reagents segment is estimated to gain the largest market share of about ~43% in the year 2035. The growth of the segment can be attributed to the increased demand for kits and reagents owing to the growing demand for precision medicine, the rising number of research activities in the field of epigenetics, and the increasing prevalence of cancer among other diseases. It is estimated that more than 74,000 genetic testing products and 300 personalized medicines are available for people suffering from different types of cancers, genetic diseases, chronic conditions, and infectious diseases. Additionally, continuous technological advancements and increasing investments in the biotechnology sector are anticipated to further drive the growth of the segment.
Technology (Methylation, Acetylation, Phosphorylation)
The global epigenetics market is segmented and analyzed for demand and supply by technology into methylation, acetylation, phosphorylation, and others. Out of these, the methylation segment is estimated to gain a significant market share of about ~37% in the year 2035. The growth of the segment can be attributed to the rising demand for DNA methylation technology in the pharmaceutical and biotechnology industries, as it helps to study the effects of environmental and dietary factors on gene expression. Additionally, the development of next-generation sequencing technologies has enabled researchers to identify methylation sites on a large scale, thereby driving the growth of the segment. The advent of next-generation sequencing technologies has allowed for the rapid and accurate identification of methylation sites, which has enabled researchers to better understand the effects of environmental and dietary factors on gene expression.
Our in-depth analysis of the global market includes the following segments:
|
By Product |
|
|
By Application |
|
|
By End User |
|
|
By Technology |
|
North American Market Forecast
The market share of epigenetics in North America, amongst the market in all the other regions, is projected to be the largest with a share of about ~35% by the end of 2035. The growth of the market can be attributed primarily to the rapid development of healthcare infrastructure and the increasing prevalence of cancer in the population. According to the American Cancer Society, as of 2022, the number of new cancer cases in the United States was estimated to be 1.9 million, and the number of cancer deaths was calculated to be 609,360. The rising number of cancer cases has increased the demand for advanced treatment options, such as epigenetics, which can help identify and target individual cancer cells. Moreover, a significant amount of money is being invested in understanding the molecular basis of cancer in the United States, with the aim of developing cancer therapeutics. Additionally, the availability of sophisticated tools and technologies, the growing focus of government initiatives on the development of life sciences, and the presence of a large number of major players in the region are some of the other factors contributing to the growth of the epigenetics market in North America.
APAC Market Statistics
The Asia Pacific epigenetics market is estimated to be the second largest, registering a share of about ~27% by the end of 2035. The growth of the market can be attributed majorly to the increasing prevalence of lifestyle diseases and growing awareness among the population about epigenetics. With the rise in lifestyle diseases such as diabetes and obesity, there is an increased demand for personalized treatments that are tailored to each person's genetic makeup. This has led to an increased focus on epigenetics, which studies how gene expression can be modified without changing the underlying genetic code. Additionally, the rise in R&D investments, supportive government initiatives and policies, and the development of innovative products in the market are some of the other factors that are propelling the growth of the Asia Pacific epigenetics market.
Europe Market Forecast
Further, the epigenetics market in Europe, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2035. The growth of the market can be attributed majorly to technological advancements, such as the development of innovative products and services, and the increasing number of collaborations and partnerships between the industry players in the region. Recent technological advancements in the field of epigenetics, such as the development of new tools and techniques to study gene expression, have enabled the rapid development of a range of products and services. This has enabled the European epigenetics market to be competitive in a world market and to develop innovative products and services to meet customer needs. Additionally, the growing awareness about epigenetics among healthcare professionals and end-users is also expected to contribute to the growth of the market in Europe.
Author Credits: Radhika Gupta, Shivam Bhutani
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?